Study identification

EU PAS number

EUPAS36199

Study ID

37707

Official title and acronym

A Cross-sectional Study Among Patients in Canada to Assess Awareness and Knowledge of the Fibristal Patient Alert Card

DARWIN EU® study

No

Study countries

Canada

Study description

This Cross-sectional study will assess patients’ receipt and use of the Fibristal Patient Alert Card, and knowledge of the key messages included in Fibristal Patient Alert Card. This study was cancelled before any data collection due to business reasons.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Ahunna Ukah

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Allergan
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable